Merck KGaA (MKGAF)
(Delayed Data from OTC)
$177.62 USD
-10.44 (-5.55%)
Updated May 24, 2024 12:54 PM ET
3-Hold of 5 3
A Value D Growth D Momentum C VGM
Balance Sheet
Fiscal Year End for Merck KGaA falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 2,685 | 2,292 | 2,453 | 1,691 | 939 |
Receivables | 4,845 | 4,804 | 4,896 | 4,273 | 4,566 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 5,019 | 4,881 | 4,614 | 3,763 | 3,743 |
Other Current Assets | 865 | 878 | 1,029 | 875 | 837 |
Total Current Assets | 13,413 | 12,855 | 12,993 | 10,601 | 10,083 |
Net Property & Equipment | 9,801 | 8,643 | 8,538 | 7,335 | 6,959 |
Investments & Advances | 1,065 | 1,011 | 1,081 | 106 | 827 |
Other Non-Current Assets | 40 | 39 | 41 | 29 | 25 |
Deferred Charges | 1,639 | 1,380 | 1,777 | 1,763 | 1,592 |
Intangibles | 26,404 | 27,095 | 29,123 | 26,972 | 29,474 |
Deposits & Other Assets | 124 | 104 | 112 | 939 | 109 |
Total Assets | 52,486 | 51,127 | 53,668 | 47,744 | 49,068 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 2,754 | 2,632 | 2,816 | 2,020 | 2,300 |
Current Portion Long-Term Debt | 760 | 1,294 | 2,994 | 2,692 | 5,096 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 1,551 | 1,562 | 1,681 | 1,668 | 1,570 |
Other Current Liabilities | 4,350 | 4,536 | 4,851 | 4,166 | 4,296 |
Total Current Liabilities | 9,415 | 10,023 | 12,342 | 10,545 | 13,263 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 1,223 | 1,348 | 1,669 | 1,646 | 2,047 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 9,999 | 9,693 | 9,784 | 11,177 | 9,681 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 2,892 | 2,664 | 4,536 | 4,938 | 4,013 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 23,530 | 23,728 | 28,332 | 28,305 | 29,006 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 612 | 595 | 668 | 645 | 2,850 |
Capital Surplus | 4,128 | 4,018 | 4,512 | 4,357 | 4,272 |
Retained Earnings | 21,893 | 19,453 | 17,905 | 14,139 | 12,888 |
Other Equity | 2,325 | 3,334 | 2,250 | 297 | 54 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 28,956 | 27,399 | 25,337 | 19,439 | 20,064 |
Total Liabilities & Shareholder's Equity | 52,486 | 51,127 | 53,668 | 47,744 | 49,068 |
Total Common Equity | 28,956 | 27,399 | 25,337 | 19,439 | 20,064 |
Shares Outstanding | NA | 129.20 | 129.20 | 129.20 | 129.20 |
Book Value Per Share | -0.29 | 212.07 | 196.11 | 150.45 | 155.29 |
Fiscal Year End for Merck KGaA falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 2,685 | 2,811 | 2,101 | 1,847 |
Receivables | NA | 4,845 | 5,169 | 5,146 | 5,036 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 5,019 | 5,410 | 5,448 | 5,249 |
Other Current Assets | NA | 865 | 1,374 | 1,501 | 1,770 |
Total Current Assets | NA | 13,413 | 14,764 | 14,196 | 13,902 |
Net Property & Equipment | NA | 9,801 | 9,490 | 9,152 | 8,821 |
Investments & Advances | NA | 1,065 | 1,081 | 1,138 | 1,033 |
Other Non-Current Assets | NA | 40 | 36 | 35 | 35 |
Deferred Charges | NA | 1,639 | 1,431 | 1,459 | 1,442 |
Intangibles | NA | 26,404 | 27,408 | 27,115 | 26,868 |
Deposits & Other Assets | NA | 124 | 104 | 96 | 107 |
Total Assets | NA | 52,486 | 54,318 | 53,192 | 52,207 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 2,754 | 2,442 | 2,620 | 2,497 |
Current Portion Long-Term Debt | NA | 760 | 1,805 | 1,843 | 2,686 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 0 | 0 | 0 | 0 |
Income Taxes Payable | NA | 1,551 | 1,721 | 1,623 | 1,568 |
Other Current Liabilities | NA | 4,350 | 3,486 | 3,560 | 3,507 |
Total Current Liabilities | NA | 9,415 | 9,453 | 9,646 | 10,257 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 1,223 | 1,234 | 1,289 | 1,308 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 9,999 | 10,383 | 10,353 | 9,831 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 2,451 | 2,711 | 2,652 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 23,530 | 23,523 | 24,000 | 24,052 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 612 | 615 | 616 | 606 |
Capital Surplus | NA | 4,128 | 4,151 | 4,159 | 4,094 |
Retained Earnings | NA | 21,893 | 22,542 | 21,546 | 20,663 |
Other Equity | NA | 2,325 | 3,488 | 2,870 | 2,792 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 28,956 | 30,795 | 29,192 | 28,155 |
Total Liabilities & Shareholder's Equity | NA | 52,486 | 54,318 | 53,192 | 52,207 |
Total Common Equity | 0 | 28,956 | 30,795 | 29,192 | 28,155 |
Shares Outstanding | 129.20 | NA | NA | NA | 129.20 |
Book Value Per Share | 0.00 | -0.29 | -0.31 | -0.29 | 217.92 |